User login
PALM BEACH, ARUBA – Systemic therapy is currently the standard of treatment for onychomycosis, but Dr. David Pariser discusses several new topical antifungals – efinaconazole, tavaborole, and luliconazole – that may be available in the next year to improve therapy options for patients.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
PALM BEACH, ARUBA – Systemic therapy is currently the standard of treatment for onychomycosis, but Dr. David Pariser discusses several new topical antifungals – efinaconazole, tavaborole, and luliconazole – that may be available in the next year to improve therapy options for patients.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
PALM BEACH, ARUBA – Systemic therapy is currently the standard of treatment for onychomycosis, but Dr. David Pariser discusses several new topical antifungals – efinaconazole, tavaborole, and luliconazole – that may be available in the next year to improve therapy options for patients.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
EXPERT ANALYSIS FROM THE CARIBBEAN DERMATOLOGY SYMPOSIUM
